CLU and metabolic dysfunction-associated steatohepatitis: Our previous studies showed that hepatocyte-specific overexpression of clusterin attenuates diet-induced NASH by activating nuclear factor erythroid 2-related factor 2 (Nrf2), a master regulator of anti-oxidant and anti-inflammation pathways28.